Levobupivacaine wound infusion — Competitive Intelligence Brief

Levobupivacaine wound infusion (Levobupivacaine wound infusion) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic. Area: Pain management / Anesthesia.

marketed Local anesthetic Voltage-gated sodium channels Pain management / Anesthesia Small molecule

Target snapshot

Levobupivacaine wound infusion (Levobupivacaine wound infusion) — University of Genova. Levobupivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes to prevent pain signal transmission at the wound site.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Levobupivacaine wound infusion TARGET	Levobupivacaine wound infusion	University of Genova	marketed	Local anesthetic	Voltage-gated sodium channels
Transdermal Lidocaine Patch	Transdermal Lidocaine Patch	University of Wisconsin, Madison	marketed	Local anesthetic	Voltage-gated sodium channels
Ropivacaine 0.2% for S-ESPB	Ropivacaine 0.2% for S-ESPB	Poznan University of Medical Sciences	marketed	Local anesthetic (amide)	Voltage-gated sodium channels
Levobupivacaine 0.5% + epinephrin 1/200000	Levobupivacaine 0.5% + epinephrin 1/200000	University Hospital, Antwerp	marketed	Local anesthetic with vasoconstrictor	Voltage-gated sodium channels; alpha-adrenergic receptors
SUP Lidocaine	SUP Lidocaine	University of Michigan	marketed	Local anesthetic	Voltage-gated sodium channels
Ropivacaine 0,75% in PENG block	Ropivacaine 0,75% in PENG block	University of Liege	marketed	Local anesthetic (amide)	Voltage-gated sodium channels
Bupivacaine Hcl 0.75% Inj	Bupivacaine Hcl 0.75% Inj	Rothman Institute Orthopaedics	marketed	Local anesthetic	Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic class)

1. University of California, San Diego · 3 drugs in this class
2. Durect · 3 drugs in this class
3. Pacira Pharmaceuticals, Inc · 3 drugs in this class
4. Wake Forest University Health Sciences · 3 drugs in this class
5. Medical University of Vienna · 3 drugs in this class
6. Imperial College London · 2 drugs in this class
7. Hvidovre University Hospital · 2 drugs in this class
8. Innocoll · 2 drugs in this class
9. George Washington University · 2 drugs in this class
10. Guy's and St Thomas' NHS Foundation Trust · 2 drugs in this class